Skip to main content

Luo Mary Z.'s Form 4 filing

Amphastar Pharmaceuticals, Inc. (AMPH) · filed Jan 10, 2024

Accession no.
0001104659-24-003050
Filed
Jan 10, 2024, 6:27 PM ET
Trade date
Jan 8-9, 2024
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 10 non-derivative transactions. Open-market sales total $12.8M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Luo Mary Z.CIK 0001611156Director, Officer (COO,Chief Scientist & Chairman), 10% Owner
Zhang Jack Y.CIK 0001611157Director, Officer (CEO & Chief Scientific Officer), 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 8, 2024Common StockSSaleDisposed−18,858$56.98−$1,074,562.781,436,744Direct
Jan 8, 2024Common StockSSaleDisposed−41,282$58.25−$2,404,474.221,395,462Direct
Jan 8, 2024Common StockSSaleDisposed−37,865$59.24−$2,243,141.531,357,597Direct
Jan 8, 2024Common StockSSaleDisposed−27,563$59.99−$1,653,622.891,330,034Direct
Jan 8, 2024Common StockSSaleDisposed−4,261$61.19−$260,742.091,325,773Direct
Jan 8, 2024Common StockSSaleDisposed−1,663$61.81−$102,784.041,324,110Direct
Jan 8, 2024Common StockSSaleDisposed−2,152$63.27−$136,148.861,321,958Direct
Jan 9, 2024Common StockSSaleDisposed−50,678$56.70−$2,873,640.241,271,280Direct
Jan 9, 2024Common StockSSaleDisposed−31,764$57.70−$1,832,871.741,239,516Direct
Jan 9, 2024Common StockSSaleDisposed−3,714$58.35−$216,719.71,235,802Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)